It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
According to doctors with the Association of American Physicians and Surgeons, over 90 percent of patients treated with hydroxychloroquine successfully recover from the coronavirus.
It is essential to start treatment against Covid-19 immediately upon clinical suspicion of infection and not to wait for confirmatory testing. There is a very narrow window of opportunity to eliminate the virus before pulmonary complications begin. The waiting to treat is the essence of the problem.
American College of Cardiology
Chloroquine, and its more contemporary derivative hydroxychloroquine, have remained in clinical use for more than a half-century as an effective therapy for treatment of some malarias, lupus, and rheumatoid arthritis. … Despite these suggestive findings, several hundred million courses of chloroquine have been used worldwide making it one of the most widely used drugs in history, without reports of arrhythmic death under World Health Organization surveillance.
Limited data on hydroxychloroquine suggest it has a low risk of causing TdP, based on its use for rheumatoid arthritis, systemic lupus erythematosus, and antimalarial therapy. … For these medications [HCQ and AZ], their time window of use is short duration, which is another reason the risk of TdP may be lower
A total of 1061 patients were included in this analysis (46.4% male, mean age 43.6 years – range 14–95 years). Good clinical outcome and virological cure were obtained in 973 patients within 10 days (91.7%). Prolonged viral carriage was observed in 47 patients (4.4%) and was associated to a higher viral load at diagnosis but viral culture was negative at day 10. All but one, were PCR-cleared at day 15. A poor clinical outcome (PClinO) was observed for 46 patients (4.3%) and 8 died (0.75%) (74–95 years old). All deaths resulted from respiratory failure and not from cardiac toxicity. Five patients are still hospitalized (98.7% of patients cured so far). PClinO was associated with older age (OR 1.11), severity at admission (OR 10.05) and low HCQ serum concentration. PClinO was independently associated with the use of selective beta-blocking agents and angiotensin II receptor blockers. A total of 2.3% of patients reported mild adverse events (gastrointestinal or skin symptoms, headache, insomnia and transient blurred vision).
originally posted by: anonentity
a reply to: Kenzo
The problem is that Hydrochloquinine is not hearsay, they wont allow the use of it. Their are two conclusions, the first is that they are idiots in charge of an emergency, the second is that they are controlling the emergency. Both outcomes are not surprising in these times.
originally posted by: infolurker
a reply to: Kenzo
originally posted by: rickymouse
a reply to: Kenzo
Zinc gets depleted when we fight infection, resulting in a loss of smell in most people. That is a symptom often of an infection.
originally posted by: tanstaafl
originally posted by: rickymouse
a reply to: Kenzo
Zinc gets depleted when we fight infection, resulting in a loss of smell in most people. That is a symptom often of an infection.
Something else that gets depleted, even more quickly, and to a greater extent...
Vitamin C.
Zinc is important, but takes a distant back seat to Vitamin C.